DEA Faces Dual Lawsuits Over HHC
By: RootSource Media, The legal battle over hemp-derived cannabinoids escalated this week as two hemp companies filed federal lawsuits challenging the DEA's decision to classify Hexahydrocannabinol (HHC) as a Schedule I controlled substance. IHC Investments and Bluestar Operations have filed separate petitions in the Ninth and Fourth Circuit Courts of Appeals, arguing that the DEA exceeded its authority by attempting…
Morris BeegleJune 2, 2026








